Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1981-10-08
1983-04-05
Lieberman, Allan
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424177, 260112B, A23J 106
Patent
active
043791425
ABSTRACT:
Thrombin inhibitor comprising a glycoprotein of a molecular weight of 68,000 to 69,000 Dalton and an isoelectric point of pH 4.5, and is further characterized in that it inhibits thrombin in the presence of dextran sulfate at least twice as strongly as in the presence of heparin, differs immunologically from antithrombin III, and does not inhibit factor Xa, plasmin and trypsin.
REFERENCES:
patent: 4087415 (1978-05-01), Bick
Chem. Abs. 81: 88767m, 1974.
Rosenberg, R. D., J. Biol. Chem., vol. 248, No. 18, pp. 6490-6505, 1973.
Briginshaw, G. F. et al., Thrombosis Res., vol. 4, pp. 463-477, 1974.
Briginshaw, G. F. et al., Archives of Biochemistry and Biophysics, vol. 161, pp. 683-690, 1974.
Port Hans
Schrenk Jurgen
Wunderwald Peter
Boehringer Mannheim GmbH
Lieberman Allan
Short Patricia
LandOfFree
Thrombin inhibitor and preparation and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitor and preparation and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitor and preparation and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-565411